This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July 2017 issue of The Ocular Surface. A downloadable version of the document and additional material, including videos of diagnostic and management techniques, are available on the TFOS website: www.TearFilm.org.
Bibliographical noteFunding Information:
The authors thank Amy Gallant Sullivan (TFOS Executive Director, USA) for raising the funds that made this TFOS DEWS II possible; Amy and Rose M. Sullivan (TFOS Operations Manager, USA) for their help in the organization of this Workshop; Nino Longo (Catania, Italy) and Sabrina Zappia (Rome, Italy) for their illustrative expertise (e.g. ); Stephanie Wong (University of Waterloo, Canada) for her technical assistance; and all participants of TFOS DEWS II for their contributions to this report. Figs. 1, 5 and 6 The TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis, Shire, Allergan, Bausch + Lomb, Akorn, CooperVision, Dompé, Horus Pharma, Lμbris Biopharma, Oculeve, TearLab, Laboratoires Théa, SIFI, Sun Pharma, Johnson & Johnson VisionCare, Carl Zeiss Meditec, Quint Health, Scope Ophthalmics and Senju.
© 2017 Elsevier Inc.